Monitoring and evaluation

Sessions

PDF version
Wednesday, 23 October

09:00

e-poster session day 1

to
Digital kiosks
e-poster session

10:50

Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research

to
Auditorium I
Major session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Support for recovery

to
Room 1.07
Short communication session

Evaluation of drug consumption rooms: guidance step by step

to
Room 1.15
Workshop

13:20

Neuroscience and cognition

to
Auditorium III
Short communication session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Gender and substance use

to
Auditorium VIII
Oral presentation session

Challenge of measuring use and impact of cannabinoids

to
Room 1.07
Oral presentation session

15:00

Measuring drug market phenomenon

to
Auditorium VI
Oral presentation session

Assessment of behavioural addictions

to
Room 5B
Oral presentation session

Quality in addictions work systems

to
Room 1.06
Oral presentation session

Conceptualising health and harms

to
Room 1.08
Short communication session

16:50

Strengthening quality in substance use disorders treatment

to
Auditorium II
Oral presentation session

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Decriminalisation and alternatives to arrest

to
Auditorium VI
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session
Thursday, 24 October

09:00

Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.

to
Room 1.10
Workshop

Workshop on conducting drug research in prison: Challenges and key recommendations from the European experience

to
Room 1.15
Workshop

10:50

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Contemporary issues

to
Room 1.08
Oral presentation session

13:20

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

European prevention curriculum: increasing the use of evidence-based prevention

to
Room 1.06
Short communication session

15:00

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

Hepatitis C testing and treatment

to
Auditorium IV
Oral presentation session

How can treatment be a better experience?

to
Auditorium VII
Oral presentation session

City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction

to
Room 1.07
Workshop

Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain

to
Room 1.08
Oral presentation session

How to respond to real-time drug alerts in European countries ?

to
Room 1.15
Workshop

16:50

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Hospital-based treatments

to
Room 5B
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

A two-phased augmentation/intervention extension of Claremont’s media-based prevention education model

to
Room 1.10
Workshop
Friday, 25 October

10:50

Alcohol: interventions and up-to-date technologies

to
Auditorium II
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Substance use and treatment needs across European prisons

to
Room 5C
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

How can cannabis policy goals inform the development of evaluation indicators?

to
Room 1.08
Workshop

13:20

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Substance use and mental health in prison settings

to
Auditorium VII
Oral presentation session

Regulating cannabis supply policies in Europe: navigating the long road to change

to
Auditorium VIII
Oral presentation session

Holistic care for mental well-being

to
Room 1.05
Short communication session

15:00

Novel psychoactive substances and latest drug trends in Asia and Pacific countries

to
Room 1.05
Oral presentation session

Presentations

Wed 23 Oct

09:00

e-poster

"How generational transmissions can shape life?" Evaluation of a genogram group therapy for people with ACoA syndrome

09:00 to 18:20
Digital kiosks
Katarzyna Iwanicka

e-poster

"Make the difference" - Qualifying professionals working with families with addiction issues

09:00 to 18:20
Digital kiosks
Rebekka Kleinat

e-poster

"Pictures (and Drugs) at an exibition"

09:00 to 18:20
Digital kiosks
Patrizio Lamonaca

e-poster

"Supersavers" manages large proportion of opioid overdoses – 5-year follow-up of a regional naloxone program, Sweden

09:00 to 18:20
Digital kiosks
Katja Troberg

e-poster

30 years of New Psychoactive Substances (NPS) in Europe. A first integrated public health assessment.

09:00 to 18:20
Digital kiosks
Julian Vicente

e-poster

A business of supplying harm reduction : a necessary evil?

09:00 to 18:20
Digital kiosks
François Destombe

e-poster

A digital approach to peer led recovery and social connection to address substance use/and or mental health challenges

09:00 to 18:20
Digital kiosks
Susan Barnes

e-poster

A feasibility and tolerability study of home-use tDCS in patients with substance use disorders (SUD)

09:00 to 18:20
Digital kiosks
Laia Miquel

e-poster

A Look at Non-Compliance: Examining Alcohol Industry Marketing Practices in Portugal

09:00 to 18:20
Digital kiosks
Hilson Cunha Filho

e-poster

A narrative review of nurse-led addiction models of care; informing the foundations for international nursing.

09:00 to 18:20
Digital kiosks
Sadie Lavelle Cafferkey

e-poster

A National Survey of Alcohol Care Teams (ACTs) in England: Characteristics of Patients and Components of Care

09:00 to 18:20
Digital kiosks
Philippa Case

e-poster

A Prospective Study: Patterns and Trends in Opioid Use and Treatment with Focus on Older Populations

09:00 to 18:20
Digital kiosks
Jo-Hanna Ivers

e-poster

A systematic review of second-hand smoking mass media campaigns (2002-2022)

09:00 to 18:20
Digital kiosks
Carmen Lim

e-poster

Activities and Experiences of Czech Adolescents in Cyberspace

09:00 to 18:20
Digital kiosks
Martin Dolejš

e-poster

Acute and Chronic Effects of Cannabis on the Neural Correlates of Working Memory in Adolescents versus Adults

09:00 to 18:20
Digital kiosks
Sorcha Hamilton

e-poster

Addiction, a volitional disorder.

09:00 to 18:20
Digital kiosks
Nicolas Figueired

e-poster

Addiction-related dreams: Interpretative Phenomenological Analysis of content and recovery from addiction

09:00 to 18:20
Digital kiosks
Shawn Rutledge

e-poster

Addictive Behaviours Workforce development: from global to European higher education programs

09:00 to 18:20
Digital kiosks
Olatz López Fernández

e-poster

ADDIRIS - Addiction and Harm Reduction: a global French-speaking network for online learning

09:00 to 18:20
Digital kiosks
Romain Bach

e-poster

Adherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine

09:00 to 18:20
Digital kiosks
Michael Frost

e-poster

Advancing Addiction Interventions: Porto's Comprehensive Approach in the Municipal Health Plan

09:00 to 18:20
Digital kiosks
Paula Pinto Oliveira

e-poster

Adverse childhood experiences, adult attachment and parenting styles in a population with addictive behaviors

09:00 to 18:20
Digital kiosks
Teodomiro Pires

e-poster

Ageing in the context of the Opioid Maintenance Treatment in Portugal: Impact of public health policies on ageing users

09:00 to 18:20
Digital kiosks
Lara Queiroz Sampaio

e-poster

Alcohol use across trials of psychological interventions for bipolar: A systematic review and meta-analysis

09:00 to 18:20
Digital kiosks
Lauren Halsall

e-poster

Alcohol, Driving and Crime - Health Care and Justice: An Outreach Intervention

09:00 to 18:20
Digital kiosks
Celestino Cunha

e-poster

Alcohol, transitions and communities of belonging within marginalised groups – towards a model of understanding.

09:00 to 18:20
Digital kiosks
Peter Nelson

e-poster

An audit of patient’s Health / Social Care needs referred to a Dual Diagnosis Social Care pathway in Ireland

09:00 to 18:20
Digital kiosks
Aidan Cooney

e-poster

An evaluation of “harm reduction” outreach service evaluative research in Macau

09:00 to 18:20
Digital kiosks
Augusto Nogueira

e-poster

Anabolic steroid use and use of other image- and performance-enhancing drugs on the rise – A new substance use disorder

09:00 to 18:20
Digital kiosks
Raphael Magnolini

e-poster

Analysis of the satisfaction survey results of users of the Mobile Drug Consumption Room Program in Lisbon

09:00 to 18:20
Digital kiosks
Adriana Almeida

e-poster

Anxiety, Depression, Stress, and Self-Harm in relation to Gaming Disorder: A Longitudinal Study of Czech Adolescents

09:00 to 18:20
Digital kiosks
Jaroslava Suchá

e-poster

Applied health research in alcohol-related liver disease: a rapid qualitative inquiry with healthcare providers

09:00 to 18:20
Digital kiosks
Sofia Hemrage

e-poster

Applying foresight research for drug policy: Lessons from the DRUG-PREP project

09:00 to 18:20
Digital kiosks
Bert Hauspie

e-poster

Are Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study

09:00 to 18:20
Digital kiosks
Said Boujraf

e-poster

Assessing Food Security and Hunger in Heroin-Assisted Treatment (HAT) Participants: Insights from Norway's HAT Project

09:00 to 18:20
Digital kiosks
Omid Dadras

e-poster

Assessing hindering and facilitating factors of help-seeking behaviour in cannabis use: descriptive qualitative study

09:00 to 18:20
Digital kiosks
Laura Väätäinen

e-poster

Assessing progress towards viral hepatitis B and C elimination in prison settings in the European region

09:00 to 18:20
Digital kiosks
Riccardo Pisetta

e-poster

Assessing the prevalence of problem gambling among the Slovenian population

09:00 to 18:20
Digital kiosks
Špela Selak

e-poster

Assessing Therapeutic Alliance: A Pilot Study Measuring Therapeutic Alliance and It's Impact on Patient Outcomes

09:00 to 18:20
Digital kiosks
Siobhan Morse

e-poster

Association between slot machine gambling and debt recovery process-Finnish population-based study with register linkage

09:00 to 18:20
Digital kiosks
Tiina Latvala

e-poster

Balancing between care and control - staff perception on the introduction of new medication for opioid agonist treatment

09:00 to 18:20
Digital kiosks
Andrea Johansson Capusan

e-poster

Barriers to Substance Use Treatment as Perceived by Professionals and Arabic Refugees in Germany

09:00 to 18:20
Digital kiosks
Ebtesam Saleh

e-poster

Benefits of a Yoga intervention in portuguese female inmates: preliminary results

09:00 to 18:20
Digital kiosks
Andreia Nisa

e-poster

Building Capacity for Social Return on Investment Analysis of Supervised Consumption Services in Saskatoon SK, Canada

09:00 to 18:20
Digital kiosks
Barbara Fornssler

e-poster

Buprenorphine prescription patterns at a tertiary care hospital in northern India: A retrospective chart review

09:00 to 18:20
Digital kiosks
Abhishek Gupta

e-poster

Burden of disease due to drug use disorders in the European Union: analysis of 1990-2019 trends and patterns

09:00 to 18:20
Digital kiosks
Vera Pinheiro

e-poster

Burnout and Engagement in Addictive Behaviors and Dependencies HCWs at Portuguese North Region: an epidemiological study

09:00 to 18:20
Digital kiosks
Cátia Coutinho

e-poster

Can we prevent the misuse of prescription stimulants? : a case report

09:00 to 18:20
Digital kiosks
Ivana Todorić Laidlaw

e-poster

Cannabis use and its link to psychopathological and functional outcomes: Insights from self-reports and hair data

09:00 to 18:20
Digital kiosks
Lydia Johnson-Ferguson

e-poster

Cannabis use and severity of cannabis dependence among Georgian small-scale cannabis growers in 2021

09:00 to 18:20
Digital kiosks
Tamari Mgebrishvili

e-poster

Cannabis use and withdrawal and escalation to psychiatric intensive care

09:00 to 18:20
Digital kiosks
Edward Chesney

e-poster

Caring with Care: VITAE’s integrative and therapeutic model towards socially vulnerable individuals

09:00 to 18:20
Digital kiosks
Brenda Sousa da Silva

e-poster

Case Series: Prospective Study on the Efficacy of Pregabalin in Managing Opioid Withdrawal Syndrome

09:00 to 18:20
Digital kiosks
Sofia Golbreich

e-poster

Catalysts for Change: Youth-Driven Insights in Opioid Harm Reduction

09:00 to 18:20
Digital kiosks
Rebeca Calzada

e-poster

Challenges and needs of Cologne's open drug scene: insights from a quantitative study on Neumarkt square

09:00 to 18:20
Digital kiosks
Daniel Deimel

e-poster

Challenges in the management of skin and soft tissue infections among people who inject drugs in Athens, Greece.

09:00 to 18:20
Digital kiosks
Apostolia Fragkouli

e-poster

Changes in self-reported alcohol use post absolute alcohol sales bans: the case of Botswana during COVID pandemic.

09:00 to 18:20
Digital kiosks
J. Maphisa Maphisa

e-poster

Characterising South Africa’s drug markets with people who sell heroin, methamphetamine and cocaine

09:00 to 18:20
Digital kiosks
MJ Stowe

e-poster

Chemsex: An Umbrella Review

09:00 to 18:20
Digital kiosks
Liam Johnstone

e-poster

Combination non-medical use of gabapentin and medications for opioid use disorder: A qualitative study

09:00 to 18:20
Digital kiosks
Mance Buttram

e-poster

Common mental disorders in prisoners with childhood trauma and substance use; the role of emotion regulation

09:00 to 18:20
Digital kiosks
Faridah Nakoma

e-poster

Community led networking and advocacy for the elimination of discrimination of women who use drugs in Europe

09:00 to 18:20
Digital kiosks
Ligia Parodi

e-poster

Comorbid bloodborne diseases among people with opioid use disorders on medication-assisted treatment in Tanzania.

09:00 to 18:20
Digital kiosks
Dorothy Mushi

e-poster

COMPARED RETENTION RATES BETWEEN PATIENTS TREATED WITH BUVIDAL IN FRANCE vs. SUBLINGUAL BUPRENORPHINE (OPALE-2 STUDY)

09:00 to 18:20
Digital kiosks
Alice Deschenau

e-poster

Comparison of HOMA-IR, Tg/Glucose Index and Tg/HDL-C ratio for predicating MetSy in HCV seronegative heroin dependents

09:00 to 18:20
Digital kiosks
Zanina Perevska

e-poster

Complicated Alcohol Withdrawal Syndrome: retrospective study of an inpatient alcohol treatment unit

09:00 to 18:20
Digital kiosks
Ines Pereira

e-poster

ComunicAr’te - Communicating through Art in Group Therapy on Addictive Behaviors

09:00 to 18:20
Digital kiosks
Carla Matias

e-poster

Conceptual competence in addiction: integrative contributions from philosophical and theoretical work in psychiatry

09:00 to 18:20
Digital kiosks
Carl Erik Fisher

e-poster

Contribution of the workforce to retention of clients in Kombani Medically Assisted Therapy (MAT) in Kwale, Kenya.

09:00 to 18:20
Digital kiosks
Esther Mumo

e-poster

Cortical thickness and brain aging in individuals engaging in unhealthy alcohol use

09:00 to 18:20
Digital kiosks
Marco Hermesdorf

e-poster

COVID-19 and earthquakes-related stress, quality of life, mental health, and internet-based addictive behaviour

09:00 to 18:20
Digital kiosks
Tina Peraica

e-poster

Crack cocaine use, street life and migrant population. An Italian observatory by ItaRdd, Cnca, Forum Droghe.

09:00 to 18:20
Digital kiosks
Luca Censi

e-poster

Critical assessment of the role of compulsory treatment of drug use disorders in Germany

09:00 to 18:20
Digital kiosks
Ingo Ilja Michels

e-poster

DCR in Paris : a constant experiment

09:00 to 18:20
Digital kiosks
Victor Detrez

e-poster

Degree of smartphone addiction in the university environment

09:00 to 18:20
Digital kiosks
Raul Vernet

e-poster

Developing a Toolkit for health care professionals working with Pregnant People who use Drugs in Southern Africa

09:00 to 18:20
Digital kiosks
Julie-Anne Mac Donnell

e-poster

Developing practical tools for identifying and supporting treatment-relevant cognitive dys/functions

09:00 to 18:20
Digital kiosks
Maria Bravo Aguilera

e-poster

Development of complementary information to drug-related deaths statistics in Slovenia

09:00 to 18:20
Digital kiosks
Mateja Jandl

e-poster

Doping Prevention among Recreational Athletes and the Role of the Police

09:00 to 18:20
Digital kiosks
Tobias Elgán

e-poster

Drug checking via Syringe Vending Machines

09:00 to 18:20
Digital kiosks
Mariam Sherozia

e-poster

Drug-Facilitated Sexual Assaults involving GHB and GBL in Europe – recent evidence and a need for better monitoring.

09:00 to 18:20
Digital kiosks
María Flores López

e-poster

Drug-Related Deaths following Bariatric surgery: Case Series Report

09:00 to 18:20
Digital kiosks
Eman Mshari

e-poster

DUDIT-E Brazilian Adaptation and TrIE-AD Application Development: A Intervention Approach for Young Drug Users

09:00 to 18:20
Digital kiosks
Richard Alecsander Reichert

e-poster

Effectiveness of the brief intervention for methamphetamine users in Poland

09:00 to 18:20
Digital kiosks
Magdalena Rowicka

e-poster

Effects of a universal school based alcohol prevention intervention

09:00 to 18:20
Digital kiosks
Bert Hauspie

e-poster

Effects of oxytocin and nicotine addiction on psychosocial stress: an fMRI study

09:00 to 18:20
Digital kiosks
Jiecheng Ren

e-poster

Efficacy of a digital intervention to reduce or stop cannabis use : study protocol for a randomized controlled trial

09:00 to 18:20
Digital kiosks
Emmanuel Lahaie

e-poster

Electroencephalographic indices of stages of reward memory and implications for therapeutic memory reconsolidation

09:00 to 18:20
Digital kiosks
Shelan Ofori

e-poster

Electronic cigarettes use among secondary school students in Slovenia

09:00 to 18:20
Digital kiosks
Helena Koprivnikar

e-poster

Empowering higher education teachers using tripartite drug awareness training model to support youth well-being

09:00 to 18:20
Digital kiosks
Munir Sewani

e-poster

Enhanced Alcohol-Specific Pavlovian-to-Instrumental Transfer in Alcohol Use Disorder

09:00 to 18:20
Digital kiosks
Michael Smolka

e-poster

Enhancing HIV Self-Testing Uptake through Syringe Vending Machines: A Case Study in Tbilisi, Georgia

09:00 to 18:20
Digital kiosks
Irma Kirtadze

e-poster

Enrichment of Prevention Methodologies with Self Help/Mutual aid practices: The case of the Centre of Prevention Greece

09:00 to 18:20
Digital kiosks
Sotiris Lainas

e-poster

Estimation of prevalence (and patterns) of cannabis use from various data sources

09:00 to 18:20
Digital kiosks
Darja Lavtar

e-poster

Ethical considerations of responsible gambling in metaverse

09:00 to 18:20
Digital kiosks
Susanne Uusitalo

e-poster

Evaluation of a UK Bristol capillary blood service for blood-borne virus detection to reach HCV elimination targets

09:00 to 18:20
Digital kiosks
Stephanie Hutchings

e-poster

Evaluation of inpatient conversion from high dose methadone to long-acting injectable buprenorphine (LAIB)

09:00 to 18:20
Digital kiosks
Stuart Fisher

e-poster

Evaluation of participants' experiences enrolled in a community-based mobile withdrawal management service

09:00 to 18:20
Digital kiosks
Andrew Lodge

e-poster

Experiences of female substance users with trauma-sensitive yoga as complementary support in addiction treatment

09:00 to 18:20
Digital kiosks
Julie Schamp

e-poster

Experiences with Xylazine among Residential Treatment Patients

09:00 to 18:20
Digital kiosks
Courtney Nordeck

e-poster

Exploring Cultural Dynamics of Black Asian Ethnic Women in Addiction Recovery

09:00 to 18:20
Digital kiosks
Shinasa Shahid

e-poster

Exploring Diverse Applications of Multicriteria Decision Analysis in Drug Policy: A Comprehensive Overview.

09:00 to 18:20
Digital kiosks
Nicola Worcman

e-poster

Exploring dual diagnosis in opioid agonist treatment: A comparative study between the Czech Republic and Norway

09:00 to 18:20
Digital kiosks
Svetlana Skurtveit

e-poster

Exploring the gendered impact on women of the impact of the changes in commissioning in drug and alcohol services.

09:00 to 18:20
Digital kiosks
Victoria Beere

e-poster

Exploring the role of gender on treatment outcomes in older adults with alcohol use disorder

09:00 to 18:20
Digital kiosks
Jeppe Tryggedsson

e-poster

Features and correlates of Internet Gaming Disorder in women and men who play video games: a cross-national study

09:00 to 18:20
Digital kiosks
Caitlin McClure-Thomas

e-poster

Fentanyl among adolescent in Poland - the scale of the phenomenon and preventive actions

09:00 to 18:20
Digital kiosks
Ewelina Silecka-Marek

e-poster

Forgotten children - losses of children growing up with addicted parents

09:00 to 18:20
Digital kiosks
Szilvia Kassai

e-poster

Framing alcohol policies in non-prohibitionist States: An existentialist dilemma?

09:00 to 18:20
Digital kiosks
Subrata Biswas

e-poster

Frequency of cannabis and amphetamine use past month in patients on opioid maintenance treatment with buprenorphine

09:00 to 18:20
Digital kiosks
Natasha Simonovska

e-poster

From intrusive memory to craving in cocaine use disorder – An ecological momentary assessment study

09:00 to 18:20
Digital kiosks
Amelie Zacher

e-poster

Gender violence experienced by women who use drugs

09:00 to 18:20
Digital kiosks
Ana Isabel Ibar-Fañanás

e-poster

Generative AI to support Harm Reduction

09:00 to 18:20
Digital kiosks
Angus Bancroft

e-poster

Global trends and Challenges of the Drug Phenomenon in Central Asia

09:00 to 18:20
Digital kiosks
Ernest Robello

e-poster

Gratitude amidst unease: Interviews with Swedish forensic psychiatric male patients with substance use disorder

09:00 to 18:20
Digital kiosks
Charlotta Svensson

e-poster

Harm Reduction: A Pathway To Community Health in Nigeria

09:00 to 18:20
Digital kiosks
Fatima Abiola Popoola

e-poster

HCV screening in the treatment centers for people with addictions: lessons learned

09:00 to 18:20
Digital kiosks
Federica Mathis

e-poster

Hepatitis C and pharmaceutical multinationals. An approach to the case of Basque Country (Spain) in 2014/2015

09:00 to 18:20
Digital kiosks
Unai Perez de San Roman Landa

e-poster

High and repeated use of MDPV induce chronic psychosis in patients with no psychiatric history

09:00 to 18:20
Digital kiosks
Andrea Anastasi

e-poster

HIV among people who inject drugs in Stockholm - prevalence, incidence and treatment outcomes

09:00 to 18:20
Digital kiosks
Martin Kåberg

e-poster

Hospitalizations due to the use of psychoactive substances in Portugal: Impact assessment of the 2008 economic crisis

09:00 to 18:20
Digital kiosks
Joana Silva

e-poster

Hybrid skills transfer of the unplugged prevention programme in a French high school abroad (Lisbon, Portugal 2023 2024)

09:00 to 18:20
Digital kiosks
Marion Fal

e-poster

Identification and treatment of alcohol use disorder with the 15-method – implementation in psychiatric care

09:00 to 18:20
Digital kiosks
Jennie Sundbye

e-poster

If you don't know where you're going, why insist on running - A reflection on the lack of data on dropout...

09:00 to 18:20
Digital kiosks
Sofia Freitas

e-poster

Image and performance enhancing drugs among gym and fitness visitors in Slovenia – preliminary results

09:00 to 18:20
Digital kiosks
Julijana Zucchiati Godina

e-poster

Impact of Adherence to the Opioid Substitution Program on Social Determinants of Health in the West Zone of Porto

09:00 to 18:20
Digital kiosks
Isabel Ponte

e-poster

Impact of first cardiovascular event versus consecutive episodes on tobacco and alcohol use: a comprehensive analysis

09:00 to 18:20
Digital kiosks
Maria Teresa Pons

e-poster

Impact of fruit smoothie supplementation on psychological distress in patients undergoing opioid agonist therapy

09:00 to 18:20
Digital kiosks
Elaheh Javadi Arjmand

e-poster

Impact of the Decriminalization on Drug Use Experiences and Related Risks among People Who Use Drugs in British Columbia

09:00 to 18:20
Digital kiosks
Cayley Russell

e-poster

Implementation of a subject on the care of addiction in the Nursing degree: origin of the need and expectations.

09:00 to 18:20
Digital kiosks
Sheimah El Beijjaji Bouzbita

e-poster

Implementation of two transdiagnostic psychological interventions for alcohol use: Study protocol, preliminary results

09:00 to 18:20
Digital kiosks
Alba Abanades

e-poster

Improving the diagnosis and clinical outcomes on drug addict patients through quantitative spectrometer testing.

09:00 to 18:20
Digital kiosks
Teodora Ciolompea

e-poster

In search of protective factors against burnout in Addictive Behaviors and Dependencies HCWs at Portuguese North Region

09:00 to 18:20
Digital kiosks
Rui Tinoco

e-poster

IN VITRO INHIBITORY POTENTIAL OF CLASSIC HALLUCINOGENS LSD, 5-MEO-DMT AND MESCALINE OVER CYTOCHROME P450 ENZYMES

09:00 to 18:20
Digital kiosks
Mariana Carvalho

e-poster

Inpatient ketamine detoxification, characterization of a treatment-seeking population with complex needs

09:00 to 18:20
Digital kiosks
Osunwale Oni

e-poster

Integrating Seven Challenges Mastery Counselling and Trauma Informed Care in adolescent substance use interventions.

09:00 to 18:20
Digital kiosks
Daniel Mercieca

e-poster

Intervention methods for the psychological problems faced by the wives of individuals with substance use disorders.

09:00 to 18:20
Digital kiosks
Ranasinghe Mudiyanselage Sanjeewani Senevirathne

e-poster

Investigating the relationship between defense styles and treatment motivation of Turkish males with alcohol use problem

09:00 to 18:20
Digital kiosks
Fatmatüz Zehra Pehlivan

e-poster

Investigating the Relationship Between Stigma and Relapse in IDUs with HIV/AIDS in Pakistan

09:00 to 18:20
Digital kiosks
Jawwad Muhammad Shujaat

e-poster

Is addiction a brain-disease? An overview of the evidence

09:00 to 18:20
Digital kiosks
Chrysanthi Blithikioti

e-poster

Is Decriminalising drugs enough? Navigating alternatives to prohibitionism

09:00 to 18:20
Digital kiosks
Jorge Quintas

e-poster

Is Integrating Online Stop Smoking Support to Existing Online Talking Therapy Support Feasible?

09:00 to 18:20
Digital kiosks
Pamela Jacobsen

e-poster

Italian teenagers’ perceived exposure to Digital Alcohol Marketing

09:00 to 18:20
Digital kiosks
Franca Beccaria

e-poster

Italian Validation of Assessment of Recovery Capital Scale in Clinical Population with Alcohol and Drugs Use Disorder

09:00 to 18:20
Digital kiosks
Teo Vignoli

e-poster

Leveraging AI to supercharge the training and support of extended workforce in addiction services

09:00 to 18:20
Digital kiosks
Christina Todorova

e-poster

LGBTQIA2S+ perspectives on problem gambling among their peers: Preliminary results of semi-structured interviews

09:00 to 18:20
Digital kiosks
Anne-Marie Auger

e-poster

Life Entrapment or Trampoline? Understanding life experiences of rejected asylum seekers in Copenhagen’s open drug scene

09:00 to 18:20
Digital kiosks
Arash Setoodeh

e-poster

Lived/Living experiences: the potential for integrative collaborations

09:00 to 18:20
Digital kiosks
Mary Beth Zeni

e-poster

Long-term Effects of the STAD-model: A Multi-Component Responsible Beverage Service Intervention

09:00 to 18:20
Digital kiosks
Johanna Gripenberg

e-poster

Long-Term Outcomes of Substance Use Treatment: A 20-Year Follow-Up Study in the Swedish Addiction Treatment System

09:00 to 18:20
Digital kiosks
Tove Sohlberg

e-poster

Love Addiction: Trait Impulsivity, Emotional Dysregulation and Attachment Style

09:00 to 18:20
Digital kiosks
Jessica Dineen

e-poster

Making Hep C treatment more accessible for addictions patients in Belfast

09:00 to 18:20
Digital kiosks
Andrew Teeney

e-poster

Mania a Potu: Review of the literature

09:00 to 18:20
Digital kiosks
Ines Valada

e-poster

Mapping drug users’ spaces of fear in Cologne, Germany

09:00 to 18:20
Digital kiosks
Bo Tackenberg

e-poster

Mapping psychedelic retreats and other practices in the EU

09:00 to 18:20
Digital kiosks
Tereza Černíková

e-poster

Meaning and Self-control in Alcohol Use and Internalizing Symptoms: Causal Insights from (Non)clinical Populations

09:00 to 18:20
Digital kiosks
Marcel Näther

e-poster

Medicinal use of non-prescribed cannabis: motives for use, perceived effectiveness and barriers to treatment (MEDUSA)

09:00 to 18:20
Digital kiosks
Lisa Strada

e-poster

Mortality among long-term prescription opioid users

09:00 to 18:20
Digital kiosks
Gabriela Rolová

e-poster

Mortality Rates and cause-specific mortality in Patients with Substance-Induced Psychosis

09:00 to 18:20
Digital kiosks
Pihla Sassi

e-poster

Navigating cannabis access in zurich: A road safety perspective from early observations of the 'Züri Can' study

09:00 to 18:20
Digital kiosks
Patricia Dürler

e-poster

Negative affectivity, mania, and defense mechanisms in compulsive online buying-shopping disorder

09:00 to 18:20
Digital kiosks
Marina Cosenza

e-poster

Neurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence

09:00 to 18:20
Digital kiosks
Elena Psederska

e-poster

New criminal legal strategies towards a more effective inmate treatment (The KETHEA PROMITHEAS project)

09:00 to 18:20
Digital kiosks
Apostolos Tsirgoulas

e-poster

Nightlife recreational contexts in Viseu: sexism, sexual violence and potential associations with substance use

09:00 to 18:20
Digital kiosks
Inês Miguel Rodrigues Armelim

e-poster

No alcohol at night – Polish experiences

09:00 to 18:20
Digital kiosks
Marta Zin-Sedek

e-poster

Offspring of individuals with alcohol use disorders and professionals in addiction counseling: A qualitative study

09:00 to 18:20
Digital kiosks
Fran Calvo

e-poster

Oniomania: a case study according to the differential diagnosis

09:00 to 18:20
Digital kiosks
Sofia Nunes

e-poster

Oniomania: what is known today?

09:00 to 18:20
Digital kiosks
Margarida Duarte

e-poster

Online gambling and betting in India and their adverse psychological and social complications: A comprehensive review

09:00 to 18:20
Digital kiosks
Shyam Sundar Kanagarajan

e-poster

Online gambling and Loneliness: A State of Knowledge.

09:00 to 18:20
Digital kiosks
Volanirina Rasolofomamonjy

e-poster

Opiate-Dependent Service Users knowledge and attitudes towards Supervised Injecting Facilities

09:00 to 18:20
Digital kiosks
Annika Gibbons

e-poster

Optimizing Overdose Response in the Emergency Department: New challenges and initiatives in Scotland

09:00 to 18:20
Digital kiosks
Lisa Schölin

e-poster

OUTCAST REGISTRATION: an archive of imprisoned female drug users' biographies

09:00 to 18:20
Digital kiosks
Ulrike Möntmann

e-poster

Packaging of disposable vaping products and e-liquids in England, Canada, and the United States: a content analysis

09:00 to 18:20
Digital kiosks
Matilda Nottage

e-poster

People with mental disorders resulting in addiction to alcohol in Poland - legal aspects of medical, social assistance.

09:00 to 18:20
Digital kiosks
Joanna Rajewska de Mezer

e-poster

Personality traits and recovery

09:00 to 18:20
Digital kiosks
Elise Constance Fodstad

e-poster

Pilot implementation of a drug overdose reporting tool among Texas harm reduction organizations: A mixed methods study

09:00 to 18:20
Digital kiosks
Jake Samora

e-poster

Piloting a strategy to prevent and manage alcohol-related problems in underage population at risk in health services

09:00 to 18:20
Digital kiosks
Carla Filipa Bruguera

e-poster

Portuguese gym-goers versus Performance-enhancing Substances: What do we know?

09:00 to 18:20
Digital kiosks
Ana Sofia Tavares

e-poster

Post-prison support for First Nations men in Australia and Canada

09:00 to 18:20
Digital kiosks
Michael Doyle

e-poster

Prevalence of BBD among PWID in treatment settings in Palestine between 2019-2023

09:00 to 18:20
Digital kiosks
Abeer Habash

e-poster

Prevalence of substance use in Austrian prison systems

09:00 to 18:20
Digital kiosks
Andrea Gamper

e-poster

Prevention Matters: Towards a National Model of Prevention (within the National Programme on Illicit Drugs 2023 - 2030)

09:00 to 18:20
Digital kiosks
Mateja Markl

e-poster

Prevention of FASD in Luxembourg – a status report

09:00 to 18:20
Digital kiosks
Jonathan Uselding

e-poster

Problematic Mobile Phone Use Related Changes in Topological Organization of Functional Brain Networks

09:00 to 18:20
Digital kiosks
Lichang Yao

e-poster

Process indicators and outcomes of patients with SUD and Emotional Disorders: Comparison of pre-post COVID-19 pandemic

09:00 to 18:20
Digital kiosks
Oscar M. Lozano

e-poster

Professional satisfaction and discontent: perspectives of health professionals on Addictive Behaviors and Dependencies

09:00 to 18:20
Digital kiosks
Rita Valinho

e-poster

Program evaluation of a team-based approach addressing mental health and addictions in a Canadian urban centre

09:00 to 18:20
Digital kiosks
Andrew Lodge

e-poster

Providing psychiatric services for hepatitis C virus patients with substance use disorders

09:00 to 18:20
Digital kiosks
Anna Gorodetsky

e-poster

Psilocin inhibits CYP450 metabolism of isoforms 2A6 and 3A4

09:00 to 18:20
Digital kiosks
Andreia Machado Brito-da-Costa

e-poster

Psychological Phenotypes in Glambling Disorder: A case study using the Pathway Model

09:00 to 18:20
Digital kiosks
Ana Llorente

e-poster

Psychosocial and financial vulnerabilities in loot box purchasing: The mediating role of problem gambling

09:00 to 18:20
Digital kiosks
Anu Sirola

e-poster

Psychosocial Determinants of Cannabis Protective Behavioral Strategies: Perceived Efficacy and Social Norms

09:00 to 18:20
Digital kiosks
Fermin Fernández Calderón

e-poster

Psychosocial Factors Affecting Drug Relapse Among Youth in Pakistan

09:00 to 18:20
Digital kiosks
Abdul Waheed Tabish

e-poster

Public Health addressing illicit drug use and mental health disorders: Interinstitutional Community Intervention Group

09:00 to 18:20
Digital kiosks
Paula Pinto Oliveira

e-poster

Recreational Cannabis and Social Media Use: A Correlational Cross-Sectional Study

09:00 to 18:20
Digital kiosks
Roni Deli-Houssein

e-poster

Recreational substance use and cognition in a large cohort of young adults with hair testing: Something is not nothing

09:00 to 18:20
Digital kiosks
Lukas Eggenberger

e-poster

Reitox National Focal Point Drug Monitoring System as a Model for Monitoring Other Addictions in Czechia

09:00 to 18:20
Digital kiosks
Pavla Chomynova

e-poster

Resilience and Sense of Coherence as Mediators in the Association between Problematic Mobile Phone Use and Depression

09:00 to 18:20
Digital kiosks
Qi Dai

e-poster

Results of İntegrated Bio-Behavioral surveillance among PWID in Azerbaijan

09:00 to 18:20
Digital kiosks
Gunash Jafarova

e-poster

Rhabdomyolysis in patients following opioid overdose

09:00 to 18:20
Digital kiosks
Aleksandra Babulovska

e-poster

Riscos & Desafios Program: the students’ voice

09:00 to 18:20
Digital kiosks
Gizela Rendo

e-poster

Risk of relapse to non-opioids among patients treated with XR-NTX or BP-NLX: A randomized clinical trial

09:00 to 18:20
Digital kiosks
Arild Opheim

e-poster

Risks and challenges of scaling up the intervention – an analysis of the program dissemination process

09:00 to 18:20
Digital kiosks
Carla Rocha

e-poster

Risky online behavior in relation to social support, depression and anxiety in Czech adolescents

09:00 to 18:20
Digital kiosks
Terezie Babilonová

e-poster

Role of Psychiatric Nursing Staff in a Newly Founded Ward for Treatment of Adolescents Facing Addiction

09:00 to 18:20
Digital kiosks
Aleš Zajc

e-poster

SCHEMATIC FUNCTIONING AND EMOTIONAL REGULATION IN ALCOHOL DEPENDENCE: A CLINICAL AND NON-CLINICAL SAMPLE COMPARISON

09:00 to 18:20
Digital kiosks
Ana Catarina Nunes da Silva

e-poster

SCIRe: Substance Consumption Informative Research - testing hair in electronic music festivals

09:00 to 18:20
Digital kiosks
Ana Pego

e-poster

Scottish stakeholder views on closing the evidence to practice gap in substance use prevention

09:00 to 18:20
Digital kiosks
Tara Shivaji

e-poster

Self-inflicted cut throat injuries and substance use during COVID-19: An analysis from Nepal

09:00 to 18:20
Digital kiosks
Dipesh Bhattarai

e-poster

Self-rated health among patients in opioid agonist therapy

09:00 to 18:20
Digital kiosks
Jan Tore Daltveit

e-poster

Sleep dysregulation in alcohol use disorders. An exploratory study with a gender perspective.

09:00 to 18:20
Digital kiosks
Ana Llorente

e-poster

Smartphone addiction and sexual distress: preliminary findings of a study in Portugal

09:00 to 18:20
Digital kiosks
Pedro Campos

e-poster

Smoking among people who use drugs

09:00 to 18:20
Digital kiosks
Ingeborg Lund

e-poster

Social work diagnosis and intervention in a harm reduction service for People Who Use Drugs

09:00 to 18:20
Digital kiosks
Teresa Castro

e-poster

Spanish version of the Bergen Social Media Addiction Scale (BSMAS): validity, reliability and measurement invariance

09:00 to 18:20
Digital kiosks
Conchita Sisi Martin

e-poster

Stigma and substance use disorders: a scoping review of patient and health care professionals’ attitudes.

09:00 to 18:20
Digital kiosks
Ashlyn Schwartz

e-poster

Stigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes

09:00 to 18:20
Digital kiosks
Theresa Caruana

e-poster

Substance Use Among College Students in India: Necessity for Intervention

09:00 to 18:20
Digital kiosks
Anju Dhawan

e-poster

Substance Use Treatment for non-speaker of the native language: Implications for migrants and the displaced

09:00 to 18:20
Digital kiosks
Mayar Nawara

e-poster

Suicidal Behaviors and Alcohol Dependence: A Comprehensive Literature Review

09:00 to 18:20
Digital kiosks
Marco Mota Oliveira

e-poster

Systematic analysis of Interventions for Opioid Use Disorder Among Adolescents

09:00 to 18:20
Digital kiosks
Joye Anestis

e-poster

Systematic review of recovery of neuropsychological function following abstinence in people with an Alcohol Use Disorder

09:00 to 18:20
Digital kiosks
Anna Powell

e-poster

Systemic biases: Attitudes of correctional staff toward incarcerated people receiving opioid agonist treatment

09:00 to 18:20
Digital kiosks
Joëlle Maguire-L

e-poster

Tell me who you are, I'll tell you what to do: designing specific interventions for different types of gamers

09:00 to 18:20
Digital kiosks
João Faria

e-poster

The addiction nursing workforce empowerment - from international perspective to the national implementation and bac

09:00 to 18:20
Digital kiosks
Vendula Pokorná

e-poster

The association between alexithymia and binge drinking among young people

09:00 to 18:20
Digital kiosks
Pelin Alpay

e-poster

The association between psychological distress and alcohol consumption and physical activity

09:00 to 18:20
Digital kiosks
Silvia Eiken Alpers

e-poster

The Autonomic Craving Signature: a biomarker of craving for personalized addiction treatment

09:00 to 18:20
Digital kiosks
Marc Auriacombe

e-poster

The comparison and analysis of blood antioxidant levels in alcohol and drug addiction

09:00 to 18:20
Digital kiosks
Nelly Sapojnikova

e-poster

The Development of an Alcohol Strategy for the Northwest Territories, Canada

09:00 to 18:20
Digital kiosks
Bryany Denning

e-poster

The effect of Cue-induced Retrieval and Reconsolidation with Episodic Foresight on craving in opioid users receiving MMT

09:00 to 18:20
Digital kiosks
Parnian Rafei

e-poster

The effect of smoking cessation interventions on socioeconomic inequalities in smoking: A Cochrane systematic review

09:00 to 18:20
Digital kiosks
Annika Theodoulou

e-poster

The effects of syringe service programs on overdose deaths in Tennessee

09:00 to 18:20
Digital kiosks
Ryan Edgerton

e-poster

The Impact of psychotherapy on Comorbid Borderline Personality Disorder and Substance Use Disorder: A Systematic Review

09:00 to 18:20
Digital kiosks
Manuel Jesús Ruiz Muñoz

e-poster

The impact of the tobacco law on hospitalizations due to the abusive consumption of psychoactive substances

09:00 to 18:20
Digital kiosks
Filipe Pinto

e-poster

The Intersection of Gambling with Smoking and Alcohol use in Great Britain: A Cross-Sectional Survey in October 2022

09:00 to 18:20
Digital kiosks
Loren Kock

e-poster

The Last Decade in Turkish Addiction Research: A Thesis-Based Analysis

09:00 to 18:20
Digital kiosks
Belgin Varol

e-poster

The lived experience of persons receiving harm reduction services, finding an oasis in the deserted life of drug use

09:00 to 18:20
Digital kiosks
Alexandros Tifas

e-poster

The Moral Improvisation of Harm Reduction in Abstinence Based Drug Policy Amongst Frontline Drug Workers in Hong Kong

09:00 to 18:20
Digital kiosks
Katie Lowe

e-poster

The necessary adaptation of a public Therapeutic Community to new needs of the treatment process.

09:00 to 18:20
Digital kiosks
Rita Fazenda Vieira

e-poster

The potential of eHealth in the treatment of substance use disorders: a perspcitive on digital theraies

09:00 to 18:20
Digital kiosks
André Almeida

e-poster

The prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis

09:00 to 18:20
Digital kiosks
Danielle Dawson

e-poster

The prevalence of Mental Health Disorders Among Cannabis Users

09:00 to 18:20
Digital kiosks
Ada Hočevar Grom

e-poster

The prevalence, risk and protective factors of the co-morbidity of neurodiversity and substance use.

09:00 to 18:20
Digital kiosks
Catherine Comiskey

e-poster

The recovery of people with addictive behaviours and dependencies: intervention strategies of social workers

09:00 to 18:20
Digital kiosks
Sara Carvalho

e-poster

The role of cartoon humor in the context of addictology efforts for the prevention of alcohol and tobacco use

09:00 to 18:20
Digital kiosks
Linda Kočvarová

e-poster

The role of coping in the association between cannabis use disorder and mental health; a one-year prospective study

09:00 to 18:20
Digital kiosks
Nora de Bode

e-poster

The role of COVID-19 in sleep quality and cognitive performance in alcohol–dependent patients

09:00 to 18:20
Digital kiosks
Lea Kozina

e-poster

The role of dissociative experiences in the link between psychological distress and Problematic Social Network Sites Use

09:00 to 18:20
Digital kiosks
Simon Ghinassi

e-poster

The role of temperamental self-regulation in predicting treatment outcome in alcohol use disorders

09:00 to 18:20
Digital kiosks
Els Santens

e-poster

THE ROLE OF WORK IN THE TREATMENT OF INDIVIDUALS RECOVERING FROM ADDICTION

09:00 to 18:20
Digital kiosks
Farshad moshiri

e-poster

The Value of Outreach (VALOR): An evaluation of the implementation of alcohol assertive outreach in Greater Manchester

09:00 to 18:20
Digital kiosks
Nikolaos Mylonas

e-poster

Therapeutic Effects of Ayahuasca: The Psychological Processes Involved in the Relief of Depression and Grief.

09:00 to 18:20
Digital kiosks
Mafalda Pinto Ribeiro

e-poster

Therapy of alcohol-dependent women serving prison sentences in Polish prisons

09:00 to 18:20
Digital kiosks
Hanna Karaszewska

e-poster

Threat or opportunity: End-user perspectives on digital interventions for treatment of cannabis use

09:00 to 18:20
Digital kiosks
Jasmin Lostedt

e-poster

Training Program for Self-management of Substance Addiction Consequences – a Randomized Controlled Trial Pilot Study

09:00 to 18:20
Digital kiosks
Paulo Seabra

e-poster

Transgender and non-binary people's experiences with alcohol reduction in the UK: A cross-sectional study

09:00 to 18:20
Digital kiosks
Dean Connolly

e-poster

TREATMENT PROGRAMS FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH MENTAL AND BEHAVIORAL DISORDERS DUE TO PAS USE

09:00 to 18:20
Digital kiosks
Andrej Kastelic

e-poster

Trilhos - Evaluation of a developmental prevention program

09:00 to 18:20
Digital kiosks
Inês Abraão

e-poster

Trust in healthcare providers for information about cannabis

09:00 to 18:20
Digital kiosks
Meredith Meacham

e-poster

Twenty years of integrated treatment of dual disorders in the netherlands: lessons learned

09:00 to 18:20
Digital kiosks
Anneke van Wamel

e-poster

Understanding Overdose Risk Perception in People who use Drugs - A Systematic Review

09:00 to 18:20
Digital kiosks
Kerry B.D. Campbell

e-poster

Unmasking addictions: exploring the role of attributional styles

09:00 to 18:20
Digital kiosks
Ana Tavares

e-poster

Use of CBD and low-THC products in North Macedonia

09:00 to 18:20
Digital kiosks
Sanja Prosheva

e-poster

Using a digital client segmentation tool among clients with problematic substance use

09:00 to 18:20
Digital kiosks
Ella Plaami

e-poster

Using Functional Near Infrared Spectroscopy to Detect Neurocognitive Differences Across Social Drinking Patterns

09:00 to 18:20
Digital kiosks
Rebecca Kuiper

e-poster

Veterinary Drugs as Toxic Adulterating Substances in the Street Drug Supply

09:00 to 18:20
Digital kiosks
Barry Logan

e-poster

Voices of the unhoused from Santa Fe, New Mexico: health status, substance use, and community harm reduction views

09:00 to 18:20
Digital kiosks
Laura Brown

e-poster

When substance use disorder and eating disorder intersect: an integrated care tool.

09:00 to 18:20
Digital kiosks
Zoya Barbier

e-poster

Willingness and Contextual Considerations for Supervised Consumption Sites among People Who Inject Drugs in Stockholm

09:00 to 18:20
Digital kiosks
Elin Holmén

e-poster

Workforce development and co production as key enablers of successful service delivery.

09:00 to 18:20
Digital kiosks
Martin Blakebrough

e-poster

Working memory in context: the role of alcohol distractors in low to heavy alcohol drinkers

09:00 to 18:20
Digital kiosks
Karis Colyer-Patel

e-poster

Working Towards Health and Wellness: The Infinite Pathways of Recovery

09:00 to 18:20
Digital kiosks
Meghann Perry

e-poster

“To smoke feels gender”: A Photovoice Study of Cannabis Use Among Transgender and Non-Binary Youth

09:00 to 18:20
Digital kiosks
Christian Barborini

10:50

Discussion

Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research

10:50 to 12:20
Auditorium I
Rosalie Liccardo Pacula
Susan Weiss
Hanan Abramovici
Beau Kilmer
François Gagnon

Short communication

A systematic review of the nuances of attachment, bonding and parenting for mothers in addiction recovery

10:50 to 12:20
Room 1.07
Louise McCulloch

Oral presentation

Bipolar disorder and severe poisoning due to medicines or illicit substances

10:50 to 12:20
Auditorium VII
Aleksi Hamina

Short communication

Embodied Storytelling: An Accessible Approach to Re-storying in the Recovery Process

10:50 to 12:20
Room 1.07
Meghann Perry

Short communication

Emotional dysregulation as a predictor of cocaine severity and withdrawal symptoms

10:50 to 12:20
Room 1.07
Alba Palazón-Llecha

Short communication

Exploring Personal Strengths and Resources in Long-Term Substance Use Disorder Recovery: Insights from Lived Experience

10:50 to 12:20
Room 1.07
Myriam Beaulieu

Oral presentation

Hazardous substance use and mental health among refugees in shared accommodations – a mixed-methods study

10:50 to 12:20
Auditorium VII
Miriam Lorenz

Oral presentation

Modelling the wider socio-economic costs of problematic opioid use in the UK

10:50 to 12:20
Auditorium VIII
George Keel

Oral presentation

Prevalence of opioid dependence in Scotland, 2015-2020: results from a Multi Parameter Estimation of Prevalence model

10:50 to 12:20
Auditorium VIII
Hayley Jones

Short communication

Recovery does not stop at discharge: A qualitative evaluation of Alcohol Recovery Navigators in North East England.

10:50 to 12:20
Room 1.07
Emma-Joy Holland

Oral presentation

Suicide-related service presentations following residential treatment for substance use disorders: a data linkage study

10:50 to 12:20
Auditorium VII
Calvert Tisdale

Short communication

The effect of Individual Placement and Support on employment outcomes for individuals with substance use disorders

10:50 to 12:20
Room 1.07
Eline Borger Rognli

Oral presentation

The impact of severe mental illness on treatment retention and all-cause mortality of people in opioid agonist treatment

10:50 to 12:20
Auditorium VII
Nicola Jones

Short communication

The role of specialist substance use and addiction treatment in building recovery capital

10:50 to 12:20
Room 1.07
Florian De Meyer

Oral presentation

Twenty-one years of heroin-related mortality in Australia: Joinpoint regression analysis of trends by age and gender

10:50 to 12:20
Auditorium VIII
Amanda Roxburgh

Oral presentation

Underestimate of deaths due to specific opioids in England and Wales for a decade

10:50 to 12:20
Auditorium VIII
Shuoqi Chen

Short communication

Understanding the process of drug addiction recovery through learning from lived experience

10:50 to 12:20
Room 1.07
Thomas Martinelli

13:20

Oral presentation

Why is a gender perspective needed in the drug field? Insight from the latest European drugs data.

13:20 to 14:50
Auditorium VIII
Linda Montanari

Short communication

Attention and reward related brain activity in cannabis users: A registered report of a longitudinal study

13:20 to 14:50
Auditorium III
Inês Macedo

Oral presentation

Changes in cannabis potency and cannabis-related harms: A 22-year ecological study in Denmark

13:20 to 14:50
Room 1.07
Kristine Rømer Thomsen

Short communication

Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders

13:20 to 14:50
Auditorium III
Jens Hetland

Short communication

Does lisdexamfetamine maintenance help or hinder cognitive function in people with current methamphetamine dependence?

13:20 to 14:50
Auditorium III
Raimondo Bruno

Short communication

Easy to reach, hard to research: cognitive function and substance use characteristics of people with severe drug use.

13:20 to 14:50
Auditorium III
Nina Auestad

Oral presentation

Gender Compression Over Time in Measures of Cannabis Use by Age and Cohort in the United States

13:20 to 14:50
Auditorium VIII
Michael Vuolo

Oral presentation

Judge Demographics and Their Impact on Sentencing of Drug Crimes

13:20 to 14:50
Auditorium IV
Sarah Henry Davis

Oral presentation

Leximetric analysis of drug laws and evaluation of outcomes: cross-country analyses approach

13:20 to 14:50
Auditorium IV
Carla Rossi

Oral presentation

Navigating the Shift: Understanding the Dynamics of Cannabis Use in Germany Amidst Legalization Prospects

13:20 to 14:50
Auditorium IV
Sally Olderbak

Short communication

Neural Correlates of Addiction: A Resting-State Meta-Analysis of Substance Use Disorders and Behavioral Addictions

13:20 to 14:50
Auditorium III
Marc Ritter

Short communication

NK1 antagonism modulates negative emotional processing in abstinent opioid dependent individuals and healthy controls

13:20 to 14:50
Auditorium III
Lexi Hand

Oral presentation

Pharmacology of generic ban-evading synthetic cannabinoid receptor agonists: are new compounds spicing up the market?

13:20 to 14:50
Room 1.07
Marie Deventer

Oral presentation

Smoking and nicotine use behaviours among women of reproductive age: a ten-year population study in England

13:20 to 14:50
Auditorium VIII
Sharon Cox

Short communication

Social Cognition in people with substance use disorders

13:20 to 14:50
Auditorium III
Sónia Rodrigues

Short communication

The bodily parallel: Bridging Gaps in Current Theories of Addiction and Interoception

13:20 to 14:50
Auditorium III
Mateo Leganes-Fonteneau

Oral presentation

The challenge of cannabis quantification: from theory to practice

13:20 to 14:50
Room 1.07
Cláudia Sousa-Reis

Oral presentation

The effects of legislative measures for 3-MMC in the Netherlands on drug sample composition and self-reported effects.

13:20 to 14:50
Auditorium IV
Pieter Oomen

Oral presentation

The perspective of transgender and non-binary people on their substance use trajectories and resilience processes

13:20 to 14:50
Auditorium VIII
Abdelhakim Missoum

15:00

Short communication

Associations between mental health and substance use in higher education students in Germany – a cross-sectional study

15:00 to 16:30
Room 1.08
Robert Hrynyschyn

Short communication

Barriers and facilitators for accessing HCV care in PWID: a qualitative study using an intersectional approach

15:00 to 16:30
Room 1.08
Ilhame Anwar

Short communication

Barriers and facilitators to accessing drug treatment services for people who use drugs in Oman: a qualitative study.

15:00 to 16:30
Room 1.08

Oral presentation

Considering the prevention workforce: a study on practitioner needs when recommending substance use interventions

15:00 to 16:30
Room 1.06
Natalie Blackburn

Oral presentation

Documenting major shifts in methamphetamine and heroin prices and purity in metropolitan and rural Victoria, Australia

15:00 to 16:30
Auditorium VI
Kasun Rathnayake

Oral presentation

Drug markets and financial flows: underground banking in the Netherlands

15:00 to 16:30
Auditorium VI
Nienke Liebregts

Oral presentation

Effects of recreational cannabis versus black market: A randomized controlled trial in Switzerland (WEED CARE)

15:00 to 16:30
Auditorium VI
Lavinia Baltes

Short communication

Envisioning youth-dedicated overdose prevention and drug consumption sites in Canada and Portugal

15:00 to 16:30
Room 1.08
Kali-olt Sedgemore

Oral presentation

Evaluating and comparing health quality for addiction treatment in the Lazio region, Italy

15:00 to 16:30
Room 1.06
Antonella Camposeragna

Short communication

Exploring the biopsychosocial needs of ageing heroin users in treatment in Malta: implications for service provision

15:00 to 16:30
Room 1.08
Anna Grech

Oral presentation

How do purity and price of cocaine affect consumption in Austria?

15:00 to 16:30
Auditorium VI
Birgit Priebe

Oral presentation

How do you make it work? A pragmatic framework for the Sustained Uptake of Service Innovations (SUSI).

15:00 to 16:30
Room 1.06
Catherine Foley

Oral presentation

Instruments assessing Gaming Disorder in children and adolescents – A systematic review of psychometric properties

15:00 to 16:30
Room 5B
Samantha Schlossarek

Short communication

Late relapse among ex-smokers using e-cigarettes following a quit attempt: a prospective one-year follow-up study

15:00 to 16:30
Room 1.08
Lion Shahab

Short communication

Mental health in people with hazardous cannabis and alcohol use - insights from a study of regulated cannabis sales

15:00 to 16:30
Room 1.08
Maximilian Buschner

Oral presentation

Planning and Monitoring drug and alcohol treatment in Denmark. The MapPlan project.

15:00 to 16:30
Room 1.06
Mads Uffe Pedersen

Oral presentation

Screening Measures on Internet Use Disorders in Children and Adolescents - A Delphi Study

15:00 to 16:30
Room 5B
Hans-Juergen Rumpf

Short communication

Substance induced psychosis among persons with concurrent mental health and substance use disorders under pandemic

15:00 to 16:30
Room 1.08
Jørgen G. Bramness

Short communication

Suicide by people in contact with drug and alcohol services: a national study 2021 to 2022

15:00 to 16:30
Room 1.08
Patrick Horgan

Oral presentation

The Gaming Disorder Identification Test (GADIT) - A screening tool for Gaming Disorder based on ICD-11

15:00 to 16:30
Room 5B
Gary Chan

Oral presentation

The Problematic Behaviour Scale (PBS-10): psychometric characteristics and cut-offs using Swiss national survey data

15:00 to 16:30
Room 5B
Sebastian Mader

16:50

Oral presentation

Application of the International Standards for the Treatment of Drug Use Disorders and the Key Quality Standards for service appraisal

16:50 to 18:20
Auditorium II
Anja Busse

Oral presentation

International Consortium on Quality in Substance Use Disorders Treatment

16:50 to 18:20
Auditorium II
Rita Notarandrea

Oral presentation

Insights from the Recipient of the first ICQ Quality Seal Award

16:50 to 18:20
Auditorium II
Michael W. Johnson

Oral presentation

PIQAT: Program for International Quality Assurance in Treatment

16:50 to 18:20
Auditorium II
Mariano Montenegro

Oral presentation

(De)criminalisation of drug possession as a litmus test of national drug policy? Experience from the Czech Republic

16:50 to 18:20
Auditorium VI
Petr Zeman

Oral presentation

20-year trends in Australian methamphetamine-related deaths: An age–period–cohort–interaction analysis

16:50 to 18:20
Auditorium IV
Oisin Stronach

Oral presentation

A Collaborative Approach to New Drug Identification in an Emerging Drug Early Warning System

16:50 to 18:20
Auditorium III
Donna Papsun

Short communication

Adão e Eva II Project – HIV, Hepatitis and other STI’s prevention and screening among hard-to-reach populations

16:50 to 18:20
Room 1.05
Paulo Anjos

Short communication

Are Australian pharmacists willing and prepared to offer Hepatitis C services? Findings from a representative sample

16:50 to 18:20
Room 1.05
Louisa Picco

Oral presentation

Assessing quality of substance use treatment in legal settings: lessons from United States drug courts

16:50 to 18:20
Auditorium VI
Steven Belenko

Short communication

Being Seen and Heard: Exploring the Relational Dimension of Heroin Assisted Treatment in Norway.

16:50 to 18:20
Room 1.06
Vegard Haukland

Oral presentation

Codeine, oxycodone, and tramadol prescription prior to overdose deaths compared to toxicological findings

16:50 to 18:20
Auditorium IV
Hilde Edvardsen

Short communication

Death after residential treatment for opioid use disorder among people using fentanyl

16:50 to 18:20
Room 1.06
Jan Gryczynski

Oral presentation

Emergence of semi-synthetic cannabinoids in Europe – a perspective from the European Union Early Warning System

16:50 to 18:20
Auditorium III
Rachel Christie

Short communication

Global utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder

16:50 to 18:20
Room 1.06
Michael Frost

Short communication

HCV antibody and RNA testing combined with nursing and peer-based outreach to enhance HCV testing and treatment among vulnerable groups

16:50 to 18:20
Room 1.05
Solange Mendes Ascensão

Short communication

Improving the model of care pathway for HCV between the drug care centres and their referral hospitals in Catalonia.

16:50 to 18:20
Room 1.05
Elena Torrell -Pedreira

Oral presentation

Law Enforcement Encounters and Decriminalization Gaps: Insights from People Who Use Drugs in Oregon Post-Measure 110

16:50 to 18:20
Auditorium VI
Morgan Godvin

Short communication

Looking under rocks: Skin infections in people who use drugs: a mixed-methods investigation in Wales

16:50 to 18:20
Room 1.05
Michelle Hughes

Oral presentation

Medical use of psychedelic substances: EUDA's monitoring of key developments

16:50 to 18:20
Auditorium VIII
Alexander Söderholm

Oral presentation

Monitoring intravenous drugs use in Spain through syringe residue analysis

16:50 to 18:20
Auditorium IV
Carlos Pernas-Fraguela

Short communication

Oxycodone and Morphine use in hospitals and primary healthcare in Norway 2010-2021

16:50 to 18:20
Room 1.06
Eirik Haarr

Oral presentation

Police drug diversion in England and Wales: Findings from a realist process evaluation

16:50 to 18:20
Auditorium VI
Alex Beerjeraz

Short communication

Prevalence and microelimination of Hepatitic C in intravenous drug users - improving linkage to care

16:50 to 18:20
Room 1.05
Eva-Carina Heier

Oral presentation

Quantifying and expanding alternatives to arrest for use and possession offences for illicit drugs

16:50 to 18:20
Auditorium VI
Caitlin Hughes

Oral presentation

Self-therapeutic use of psilocybin, MDMA and ketamine among Dutch nightlife attendees.

16:50 to 18:20
Auditorium VIII
Frederiek Schutten

Short communication

STTBI risk reduction with OAT among people with prescription-type opioid use disorder

16:50 to 18:20
Room 1.05
M. Eugenia Socias

Oral presentation

Synthetic cathinones in drug-related deaths – an alarming issue or triviality?

16:50 to 18:20
Auditorium III
Ilkka Ojanperä

Oral presentation

The U.S. Psilocybin Landscape: Policy Evolution and Nationally Representative Insights

16:50 to 18:20
Auditorium VIII
Beau Kilmer

Oral presentation

Trends in GHB use and harms in Australia

16:50 to 18:20
Auditorium III
Rachel Sutherland

Short communication

Trends in the detection and co-detection of drugs in a population attending opioid agonist treatment: 2010 to 2020

16:50 to 18:20
Room 1.06
Gráinne Cousins

Oral presentation

What are the reasons for injecting methadone? A qualitative study among people who inject drugs in Barcelona

16:50 to 18:20
Auditorium IV
Gabriela Barbaglia
Thu 24 Oct

10:50

Oral presentation

Long-acting injectable buprenorphine for opioid use disorder: key findings from a longitudinal qualitative study

10:50 to 12:20
Auditorium IV
Joanne Neale

e-short communication

Ensuring Quality Care: community-led monitoring of client satisfaction and accessibility of OAT programs

10:50 to 12:20
Auditorium IV
Maria Plotko

Oral presentation

Adapting Opioid Therapy: Transition from Methadone to Slow-Release Morphine Amid COVID-19 Supply Chain Disruptions

10:50 to 12:20
Auditorium IV
Artūras Barkus

Oral presentation

A Holistic Multi-Disciplinary Healthcare Pathway for Older Men who use Anabolic Androgenic Steroids

10:50 to 12:20
Room 1.08
Evelyn Hearne

Short communication

A scoping review of mass media interventions intended to reduce stigma towards people who use drugs

10:50 to 12:20
Auditorium VII
Adam Holland

Oral presentation

A wastewater-based approach to monitor shifting trends in illicit drugs consumption in Switzerland

10:50 to 12:20
Room 5A
Livia Andrani

Oral presentation

Cannabis policy and practice in Finland: from social media discussions to citizens initiatives

10:50 to 12:20
Room 1.08
Aleksi Hupli

Short communication

Changes in the use of non-prescribed hydromorphone and unregulated opioids use in Vancouver, Canada, 2018-2022

10:50 to 12:20
Auditorium VII
Kanna Hayashi

Short communication

Definition of public amenity in drug consumption room literature: A scoping review

10:50 to 12:20
Auditorium VII
Bianca Whiteside

Oral presentation

Drugs and climate change: knowledge gaps in monitoring environmental impacts of drugs

10:50 to 12:20
Room 1.08
Tim Surmont

Short communication

Enhancing Harm Reduction: A Qualitative Evaluation of Athens' Drug Consumption Room

10:50 to 12:20
Auditorium VII
Benjamin Scher

Oral presentation

European Hair Drug Analisys Network – A pioneer study to investigate the use of NPS and NSO

10:50 to 12:20
Room 5A
Elisa Fornero

Oral presentation

Impact of long-acting depot buprenorphine post-release from custody– Early findings from the Release Study

10:50 to 12:20
Auditorium IV
Adrian Dunlop

Oral presentation

Key challenges for alcohol epidemiology and alcohol control policy evaluation

10:50 to 12:20
Auditorium VI
Jürgen Rehm

Oral presentation

Legally grey? Drug checking perspectives in the CEECA region

10:50 to 12:20
Auditorium VI
Eliza Kurcevič

Short communication

Overdoses in the drug consumption room in Oslo: route of administration matters!

10:50 to 12:20
Auditorium VII
Desiree Eide

Oral presentation

Perceptions of family physicians in Istanbul on e-cigarettes as smoking cessation aids

10:50 to 12:20
Room 1.08
Melis Selamoglu

Oral presentation

Public health for whom? Unpacking the assumptions and silences in Canada's public health approach to substance use.

10:50 to 12:20
Auditorium VI
Sophie Henderson

Short communication

Reasons for (non-)using a drug consumption room: the point of view of drug users.

10:50 to 12:20
Auditorium VII
Sanda Samitca

Short communication

Safe Inhalation Pipe Provision Study: Intervening to improve policy and practice for people who use crack in England.

10:50 to 12:20
Auditorium VII
Magdalena Harris

Oral presentation

Synthesis of multisource data for the development of an advanced dashboard to monitor illicit drugs markets

10:50 to 12:20
Room 5A
Pierre Esseiva

Oral presentation

The Costs and Harms of Substance Use in Canada: Key Trends from 2007 to 2022

10:50 to 12:20
Auditorium VI
Pam Kent

Short communication

The Value of Peer Research: A Peer Perspective

10:50 to 12:20
Auditorium VII
Christos Anastasiou

Oral presentation

What can Portugal do to prevent be caught off guard again in the drug domain?

10:50 to 12:20
Room 5A
Alcina Correia

13:20

Short communication

Making a case for health promotion theoretically underpinned policies and practices around alcohol in workplace settings

13:20 to 14:50
Room 1.06
Lolita Alfred

Short communication

Introducing the European Prevention Curriculum (EUPC) in Austria – findings from a pilot implementation

13:20 to 14:50
Room 1.06
Martin Busch

Short communication

Advancing Science-Based Prevention: Insights from the EUPC Training in Bosnia and Herzegovina

13:20 to 14:50
Room 1.06
Amir Hasanovic

Short communication

Piloting EUPC Training in the Republic of Georgia: Lessons Learned

13:20 to 14:50
Room 1.06
Jana D. Javakhishvili

Short communication

TRAINING ON THE EUROPEAN PREVENTION CURRICULUM (EUPC) FOR DOPs- THE CYPRIOT EXPERIENCE

13:20 to 14:50
Room 1.06
Maria Matheou

Short communication

The Frontine Politeia project: the need for involving prevention implementers within substance use and crime prevention

13:20 to 14:50
Room 1.06
Annemie Coone

Short communication

Strengthening the capacity and agency of drug prevention stakeholders on the key issue of evidence-based prevention.

13:20 to 14:50
Room 1.06
Rachele Donini

Short communication

A multisite implementation trial of collaborative care for Opioid Dependence: 3-month outcomes from the EPIC-MATOD trial

13:20 to 14:50
Room 1.05
Suzanne Nielsen

Short communication

A socio-ecological systematic review of harm reduction interventions addressing the U.S. opioid overdose epidemic

13:20 to 14:50
Room 1.05
Katie McCormick

Short communication

An economic evaluation of Catalonia’s Needle Exchange Programme (NEP). Cost-Benefit analysis

13:20 to 14:50
Room 1.05
Asier Narbarte Arzuaga

Oral presentation

Associations between opioid agonist therapy exposure and chronic pain characteristics among people who inject drugs

13:20 to 14:50
Auditorium IV
Sasha Udhesister

Short communication

Effect of integrated smoking cessation treatment on smoking intensity among persons who receive opioid agonist treatment

13:20 to 14:50
Room 1.05
Karl Trygve Druckrey-Fiskaaen

Short communication

Empowering Global Drug Prevention: A Systematic Approach

13:20 to 14:50
Room 1.06
Ali Yassine

Short communication

Homeless people and mental health: an observational study in an Emergency Shelter in Lisbon

13:20 to 14:50
Room 1.05
Gonçalo Henriques

Short communication

Multi Parameter Estimation of Prevalence modelling: methods to estimate the prevalence of opioid dependence in Scotland

13:20 to 14:50
Room 1.05
Andreas Markoulidakis

Short communication

Treatment pathways and transitions of young adults during opioid maintenance treatment

13:20 to 14:50
Room 1.05
Sanna Iivonen

15:00

Oral presentation

Experiences of building a Prompt Response Network for emerging drugs of concern in Australia

15:00 to 16:30
Room 1.05
Brendan Clifford

Oral presentation

Emerging Drug trends in Japan: rethinking prevention strategies

15:00 to 16:30
Room 1.05
Hironobu Fujiwara

Oral presentation

Exploring Novel Psychoactive Substances Among Kazakhstan's Youth: A Focus on Emerging Trends and Risks

15:00 to 16:30
Room 1.05
Mariya Prilutskaya

Oral presentation

The case of Kratom: from traditional medical to recreational use

15:00 to 16:30
Room 1.05
Vicknasingam Balasingam

Oral presentation

25 years of monitoring the Dutch cannabis market using chemical analys: trends, developments and technical discussion

15:00 to 16:30
Room 1.08
Pieter Oomen

Oral presentation

A national program to scale-up decentralized HCV point-of-care testing and treatment in Australia

15:00 to 16:30
Auditorium IV
Jason Grebely

Oral presentation

Brorphine analogues as new psychoactive substances: in vitro and in vivo pharmacological characterization

15:00 to 16:30
Auditorium III
Marthe Vandeputte

Oral presentation

Dropout from addiction treatment: predictors, patient profiles, outcomes, and recommendations to improve care.

15:00 to 16:30
Auditorium VII
Marie-Josee Fleury

Oral presentation

Drug monitoring by samples seized at 2018, 2022 and 2023 BOOM festival editions

15:00 to 16:30
Room 1.08
Carla Filipa Ferreira

Oral presentation

HCV Community-led monitoring: from consultation to effective policy contributions

15:00 to 16:30
Auditorium IV
Lynn Jefferys
Joana Canedo

Oral presentation

In vitro cannabinoid activity-based screening of seized plant materials: a future-proof harm reduction strategy?

15:00 to 16:30
Auditorium III
Axelle Timmermamn

Oral presentation

LECUCA: Analysis of Brazil's largest open drug scene using time-series cross-sectional survey data

15:00 to 16:30
Room 1.08
Clarice Madruga

Oral presentation

Modelling the impact of scaling up of HCV case finding and treatment for people who inject drugs in England

15:00 to 16:30
Auditorium IV
Zoe Ward

Oral presentation

Neurotoxicity of synthetic cathinones: Can metabolism play a role?

15:00 to 16:30
Auditorium III
Alexandra Antunes

Oral presentation

Pharmacology of 30 semisynthetic cannabinoids – and why details matter when assessing the harm potential of seized drugs

15:00 to 16:30
Auditorium III
Christophe Stove

Oral presentation

Pilot HCV Birth Cohort Screening in UK Primary Care using a postal oral fluid home testing kit: the HEPCAPP StudyPP STUDY

15:00 to 16:30
Auditorium IV
Matt Hickman

Oral presentation

Service user and Carer perspective on Treatment for Co-Occurring Mental Health and Substance Use Problems (RECO Study)

15:00 to 16:30
Auditorium VII
Elizabeth Hughes

Oral presentation

The use of patient-reported outcomes in residential alcohol & drug services in Belgium: findings from the OMER-BE study

15:00 to 16:30
Auditorium VII
Amine Zerrouk

Oral presentation

Trends in illicit and licit substance use across Spain – A comprehensive three-year wastewater-based epidemiology study.

15:00 to 16:30
Room 1.08
José Benito Quintana

16:50

Oral presentation

Epidemiology of injecting drug use and injection related harms among people who are incarcerated

16:50 to 18:20
Auditorium IV
Louisa Degenhardt

Short communication

A comparison of sales regulations across three types of cannabis dispensaries: First insights from the 'Züri Can' study

16:50 to 18:20
Room 1.06
Nadine Heckel

Oral presentation

Acute drug-toxicity presentations involving polydrug use to Euro-DEN Plus sentinel hospitals in Europe from 2014 to 2022

16:50 to 18:20
Room 5B
Peter Heudtlass

Oral presentation

Context specific factors that impact on the optimal scale up of hepatitis C testing and treatment in the UK

16:50 to 18:20
Auditorium IV
Peter McCulloch

Oral presentation

Data collection on acute drug toxicity using the Euro-DEN plus model in countries bordering the European Union

16:50 to 18:20
Room 5B
Thomas Néfau

Oral presentation

Inpatient admissions in people with opioid dependence: a portuguese population-based observational retrospective study

16:50 to 18:20
Room 5B
José Miguel Paupério

Oral presentation

It is time to take nitrous oxide seriously

16:50 to 18:20
Room 5C
Julaine Allan

Short communication

Managing the drug-driver: insights from Victoria’s large-scale roadside testing program

16:50 to 18:20
Room 1.06
Michael Fitzharris

Short communication

Metabolite profile of synthetic cannabinoids seized in Portugal

16:50 to 18:20
Room 1.06
Rita Padinha Lopes

Oral presentation

Nangs in Australia: Investigating nitrous oxide use among people who regularly use MDMA and/or other illicit stimulants

16:50 to 18:20
Room 5C
Jodie Grigg

Oral presentation

New challenges for outpatient care: trends from twenty years of monitoring treatment demand in the city of Hamburg

16:50 to 18:20
Room 5C
Marcus Martens

Oral presentation

Non-Fatal Overdose: A Decade-Long Analysis of Inner-City Hospitals and Nationwide Trends Across Ireland (2011-2021)

16:50 to 18:20
Room 5B
Jo-Hanna Ivers

Oral presentation

Population aging and apparent decline in initiation of injecting drug use in Australia

16:50 to 18:20
Room 5C
Olivia Price

Short communication

Project on fine default prisoners with substance abuse problems – preliminary findings of an evaluation and impact study

16:50 to 18:20
Room 1.06
Jukka Leinonen

Short communication

Recommendations from the government cannabis committee on the legal availability of vaping products.

16:50 to 18:20
Room 1.06
Robert Perreault

Oral presentation

The development of a toolkit to support the elimination of viral hepatitis B and C in prisons

16:50 to 18:20
Auditorium IV
Erika Duffell

Short communication

The experience of aging among patients in opioid assisted treatment. A qualitative study.

16:50 to 18:20
Room 1.06
Siv-Elin Leirvåg Carlsen

Short communication

The impact of Cannabis market Regulation on adolescents in Uruguay

16:50 to 18:20
Room 1.06
Leticia Keuroglian

Oral presentation

Towards elimination of hepatitis C in Oslo: cross-sectional prevalence studies in 2018, 2021, 2022 and 2023

16:50 to 18:20
Auditorium IV
Eirik Opheim
Fri 25 Oct

10:50

Oral presentation

Effectiveness of Machine Learning Based Adjustments to an eHealth Intervention Targeting at Risk Alcohol Use

10:50 to 12:20
Auditorium II
Matthijs Blankers

Oral presentation

Identification and treatment of AUD with the 15-method – Evaluating effectiveness of the method in Danish primary care

10:50 to 12:20
Auditorium II
Anette Søgaard Nielsen

Oral presentation

Smartphone-Delivered Cognitive Bias Modification for Reducing Harmful Drinking amongst middle – older age adults

10:50 to 12:20
Auditorium II
Victoria Manning

Oral presentation

Advancing Harm Reduction and Saving Lives: A Comprehensive Evaluation of Initiatives and Outcomes in Greece.

10:50 to 12:20
Room 5A
Athanasios Theocharis

Short communication

An action plan for synthetic opioids - The Zurich approach

10:50 to 12:20
Room 1.05
Dominique Schori

Oral presentation

An online survey of cannabis users and ex-users in Ireland

10:50 to 12:20
Room 5B
Philip James

Short communication

Community attitudes towards sanction and health-based interventions for individuals caught drug-driving in Australia

10:50 to 12:20
Room 1.05
Sara Liu

Short communication

Development of an evidence-based classification framework for psychoactive substances in the illicit drug market

10:50 to 12:20
Room 1.05
Michèle Boileau-Falardeau

Oral presentation

Do Self-Report Drug Use Surveys Produce the Same Results in Print and Online Mode? Findings from a Dual Mode Survey.

10:50 to 12:20
Room 5B
Stelios Stylianou

Oral presentation

Drug checking: a harm reduction intervention to address the illicit drug toxicity crisis in a Canadian setting

10:50 to 12:20
Room 5A
Lianping Ti

Oral presentation

Drug use in French prisons. Results of the ESSPRI survey

10:50 to 12:20
Room 5C
Caroline Protais

Short communication

Gabapentinoids in Ireland (2010-2020): trends in prescribing, law enforcement drug seizures & post-mortem toxicology

10:50 to 12:20
Room 1.05
Gráinne Cousins

Short communication

Increasing availability and production of synthetic cathinones in Europe – a perspective from the EU EWS

10:50 to 12:20
Room 1.05
Gregorio Planchuelo

Short communication

MDMA misinformation: what dealers claim versus the actual MDMA content in ecstasy pills in the netherlands

10:50 to 12:20
Room 1.05
Lavinia Stegemann

Oral presentation

Needs & Modalities of Drug checking for Drug Users: Perspective of People with Lived Experience and Service Providers.

10:50 to 12:20
Room 5A
Jean-Sébastien Fallu

Short communication

New research unit provides evidence to address national addictions policy challenges

10:50 to 12:20
Room 1.05
Leonie Brose

Oral presentation

Online approach and characteristics of the hidden population with substance use disorder that doesn’t reach treatment

10:50 to 12:20
Room 5B
Ilias Paraskevopoulos

Oral presentation

Prison-based treatment needs for people with a history of substance use disorder: A nationwide cohort study

10:50 to 12:20
Room 5C
Birgitte Thylstrup

Oral presentation

Substance use and psychological states in imprisoned population in Greece—Key findings from a recent nationwide survey

10:50 to 12:20
Room 5C
Ioulia Bafi

Short communication

The emergence of nitazenes on the Irish heroin market: Lessons learned and challenges moving forward

10:50 to 12:20
Room 1.05
Nicki Killeen

Oral presentation

What can we learn about poly-drug use among frequent cannabis users? results from the European Web Survey on Drugs

10:50 to 12:20
Room 5B
Davide Fortin

Oral presentation

What you might do versus what you actually do: measuring participant drug behaviours in drug checking services

10:50 to 12:20
Room 5A
Anna Olsen

13:20

Oral presentation

Update on the situation in the Netherlands (tbc)

13:20 to 14:50
Auditorium VIII
Margriet Van Laar

Oral presentation

Cannabis law reform in Switzerland: purpose, opportunities, and risks of local pilot projects

13:20 to 14:50
Auditorium VIII
Frank Zobel

Oral presentation

Issues of transport, driving safety & intoxication for opioid agonist treatment clients in New South Wales, Australia

13:20 to 14:50
Auditorium VI
Daniel Winter

Oral presentation

Cannabis law reform in Germany: a rocky road to a partial legalisation

13:20 to 14:50
Auditorium VIII
Jakob Manthey

Oral presentation

Physical conditions and associated health service utilization among individuals with substance-related disorders

13:20 to 14:50
Auditorium VI
Christophe Huỳnh

Oral presentation

Cannabis law reform in Luxembourg: first observations after its change among recreational cannabis users and non-users

13:20 to 14:50
Auditorium VIII
Nadine Berndt

Oral presentation

The effect of substance use disorders on vaccine uptake, acceptance, and adherence: a global systematic review

13:20 to 14:50
Auditorium VI
Eva Maria Havelka

Oral presentation

Out of treatment drug and alcohol users in England: ‘Unmet Treatment Need’?

13:20 to 14:50
Auditorium VI
Charlie Lloyd

Short communication

Addressing the needs of individuals with concurrent disorders: a complexity arising

13:20 to 14:50
Room 1.05
karine Gaudreault

Short communication

Breaking Chains: Interventions for Reducing Internalized Stigma and Boosting Self-Esteem in Substance Use Behaviors

13:20 to 14:50
Room 1.05
Andreia Florido

Short communication

Functional recovery among patients with dual disorders: the role of stigma

13:20 to 14:50
Room 1.05
Nusa Segrec

Short communication

Intervention variability predicts social rehabilitation indicators at discharge in long-term residential treatment.

13:20 to 14:50
Room 1.05
Katia Barreto

Oral presentation

Interventions to reduce harms related to drug use among people who experience incarceration: A systematic review

13:20 to 14:50
Auditorium VII
Christel Macdonald

Short communication

Mitigating Trauma and Problematic Drug Use with a Focus on Empathy – Insights from Metzineres

13:20 to 14:50
Room 1.05
Aura Roig Forteza

Oral presentation

PRS20: drug use and perceived mental health concerns among people living in prison in the Grand-Duchy of Luxembourg

13:20 to 14:50
Auditorium VII
Tom Kugener

Oral presentation

Radio theater-based prison artistic intervention: a mixed-method evaluation

13:20 to 14:50
Auditorium VII
Isabel Silva

Short communication

Towards a better connection

13:20 to 14:50
Room 1.05
Chico Taguba

Short communication

Trauma-Informed care approach with people who use drugs

13:20 to 14:50
Room 1.05
Joana Pires